Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease

Imagem de Miniatura
Arquivos
art_BLATYTA_Prevalence_of_serologic_markers_of_transfusion_and_sexually_2020.PDF.pdf (273.65 KB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
KELLY, Shannon
PREISS, Liliana
MENDES, Franciane
CARNEIRO-PROIETTI, Anna B.
RODRIGUES, Daniela de Oliveira Werneck
MOTA, Rosimere
LOUREIRO, Paula
MAXIMO, Claudia
Citação
TRANSFUSION, v.60, n.2, p.343-350, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: Patients with sickle cell disease (SCD) often require red blood cell (RBC) transfusion for clinical complications, so may be exposed to transfusion-transmitted infections (TTIs). The prevalence of markers for human immunodeficiency virus (HIV), hepatitis C virus (HCV) and B (HBV), human T-cell lymphotropic virus (HTLV-1/2), Chagas disease, and syphilis in an SCD cohort in Brazil were studied. STUDY DESIGN AND METHODS: Clinical history, interview data, blood samples, and medical chart review data were collected during cohort enrollment from November 2013 to May 2015. Serologic markers of infection were assessed. Standard measures of statistical association were calculated, and multivariable models were developed for the most prevalent infections to identify associated factors. RESULTS: Infectionmarkers were evident in 5.2% (144/2779) of the enrolled cohort. Anti-HCV was detected in 69 (2.5%), syphilis antibodies in 34 (1.2%), anti-HTLV-1/2 in 17 (0.6%), HBV surface antigen in 13 (0.5%), Chagas disease antibodies in 13 (0.5%), and anti-HIV in 8 (0.3%) of participants. Factors associated with increased odds of being anti-HCV reactive were older age, illegal drug use, increasing number of RBCs, more than three pain crises in the previous year, and geographic location. Syphilis was associated with older age, females, and smoking history. CONCLUSION: HCV infection was more common in older patients who may have received RBCs before testing was performed on donations, suggesting possible historic transfusion transmission. The cohort showed decreasing rates of infections and a reduction in transfusion transmission markers in younger patients compared to historical literature except for syphilis, indicating contemporary reduced risk of TTI.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/36867
Referências
  1. Agasa SB, 2010, TRANSFUS CLIN BIOL, V17, P254, DOI 10.1016/j.tracli.2010.09.002
  2. Avert, HIV AIDS BRAZ GLOB I
  3. Bagasra O, 1998, AM J HEMATOL, V59, P199, DOI 10.1002/(SICI)1096-8652(199811)59:3<199::AID-AJH4>3.0.CO;2-L
  4. BENZAKEN AS, 2018, B EPIDEMIOLOGICO HEP, V49, P22
  5. Carneiro-Proietti ABF, 2018, BRIT J HAEMATOL, V182, P895, DOI 10.1111/bjh.15462
  6. Catalan-Soares Bernadette, 2005, Cad. Saúde Pública, V21, P926, DOI 10.1590/S0102-311X2005000300027
  7. Chies JAB, 2003, BRAZ J MED BIOL RES, V36, P71, DOI 10.1590/S0100-879X2003000100010
  8. DASILVA EC, 2016, REV PAN-AMAZ SAUDE, V7, P39, DOI 10.5123/S2176-62232016000100005
  9. de Almeida-Neto C, 2013, TRANSFUSION, V53, P827, DOI 10.1111/j.1537-2995.2012.03840.x
  10. Barros MBD, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0439-0
  11. Souto FJD, 2016, REV SOC BRAS MED TRO, V49, P11, DOI 10.1590/0037-8682-0176-2015
  12. Ferreira OD, 2018, MEDICINE, V97, pS3, DOI 10.1097/MD.0000000000009218
  13. Guo C, 2017, J SEX MED, V14, P659, DOI 10.1016/j.jsxm.2017.03.249
  14. IDE LE, 2015, NIGER HLTH J, V15, P18
  15. Jayawardena T, 2019, VOX SANG, V114, P107, DOI 10.1111/vox.12741
  16. Kato GJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.10
  17. Khalek MAA, 2012, EGYPT RHEUMATOL, V34, P91, DOI 10.1016/j.ejr.2012.04.001
  18. Kleinman S, 2014, TRANSFUSION, V54, P942, DOI 10.1111/trf.12468
  19. Kretzer IF, 2014, SCI WORLD J, DOI 10.1155/2014/827849
  20. Kumari N, 2016, BLOOD ADV, V1, P170, DOI 10.1182/bloodadvances.2016000745
  21. Malta Deborah Carvalho, 2015, Rev. bras. epidemiol., V18, P45, DOI 10.1590/1980-5497201500060005
  22. Morasco BJ, 2014, J BEHAV MED, V37, P902, DOI 10.1007/s10865-013-9549-y
  23. Neto JPM, 2011, T ROY SOC TROP MED H, V105, P121, DOI 10.1016/j.trstmh.2010.11.007
  24. Nouraie M, 2012, SEX TRANSM INFECT, V88, P528, DOI 10.1136/sextrans-2011-050459
  25. Ogunrinde G. O., 2005, Annals of African Medicine, V4, P104
  26. Owusu EDA, 2015, CLIN INFECT DIS, V60, P612, DOI 10.1093/cid/ciu832
  27. de Cerqueira LRP, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759078, 10.1590/s1678-9946201759078]
  28. Dias JCP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000500002, 10.5123/s1679-49742016000500002]
  29. Pinto Valdir Monteiro, 2014, Rev. bras. epidemiol., V17, P341, DOI 10.1590/1809-4503201400020005ENG
  30. Schabath MB, 2012, CANCER EPIDEM BIOMAR, V21, P102, DOI 10.1158/1055-9965.EPI-11-0591
  31. Vianna EN, 2017, MEM I OSWALDO CRUZ, V112, P760, DOI 10.1590/0074-02760170061
  32. Wendland EM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-031602
  33. Wolle CC, 2011, REV BRAS PSIQUIATR, V33, P367, DOI 10.1590/S1516-44462011000400010

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Carregar mais